Riferimento farmaci
Sucroferric oxyhydroxide
Sucroferric oxyhydroxide is a medicine in the class genitourinary. It is used for serum phosphorus regulation.
- Classe del farmaco: Genitourinary
- Indicato per: serum phosphorus regulation
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Genitourinary
- Codice ATC
- V03AE05
- Dosaggi comuni
- 500 mg
- Interazioni note
- 5 (Moderata: 3 · Minore: 2)
- Nomi commerciali
- 2
- Paesi e mercati
- 2
Per cosa si usa
Come agisce
Phosphate binding occurs in the GI tract by ligand exchange between hydroxyl groups and/or water in sucroferric oxyhydroxide and dietary phosphate. Bound phosphate is eliminated in feces, reducing serum phosphorus and calcium-phosphorus product.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Control of serum phosphorus in CKD on dialysis: starting dose one 500 mg tablet three times daily with meals, oral; adjust by one 500 mg tablet per day as needed, titrating as often as weekly; doses up to 3,000 mg per day have been studied
Gravidanza e allattamento
- Gravidanza
- Unknown Not systemically absorbed; maternal use is not expected to result in fetal exposure. Animal studies showed some effects at high doses in rabbits and rats.
- Allattamento
- Unknown Not systemically absorbed; breastfeeding is not expected to result in infant exposure.
Effetti indesiderati segnalati
- Diarrhea
- Discolored feces
- Nausea
- Product taste abnormal
- Tooth discoloration
- Rash
Chi deve prestare attenzione
- Patients with peritonitis during peritoneal dialysis, significant gastric or hepatic disorders, recent major GI surgery, hemochromatosis or other iron accumulation diseases were not studied; monitor effect and iron homeostasis.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (5)
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Sucroferric oxyhydroxide: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Domande frequenti
What is Sucroferric oxyhydroxide used for?
Sucroferric oxyhydroxide is a medicine in the class genitourinary. It is used for Serum phosphorus regulation.
What side effects have been reported with Sucroferric oxyhydroxide?
Diarrhea, Discolored feces, Nausea, Product taste abnormal, Tooth discoloration, Rash.
Can Sucroferric oxyhydroxide be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Not systemically absorbed; maternal use is not expected to result in fetal exposure. Animal studies showed some effects at high doses in rabbits and rats. Breastfeeding: Unknown. Not systemically absorbed; breastfeeding is not expected to result in infant exposure.
What does Sucroferric oxyhydroxide interact with?
MediHelp lists 5 known interactions for Sucroferric oxyhydroxide. Moderate: 3 · Minor: 2. The most serious include Alendronate, Doxycycline, Levothyroxine.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
